Carmell Therapeutics Stock Alpha and Beta Analysis
| CTCX Stock | 0.30 0.02 7.14% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Carmell Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Carmell Therapeutics over a specified time horizon. Remember, high Carmell Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Carmell Therapeutics' market risk premium analysis include:
Beta 6.61 | Alpha (0.94) | Risk 13.68 | Sharpe Ratio (0) | Expected Return (0.03) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Carmell |
Carmell Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Carmell Therapeutics market risk premium is the additional return an investor will receive from holding Carmell Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Carmell Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Carmell Therapeutics' performance over market.| α | -0.94 | β | 6.61 |
Carmell Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Carmell Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Carmell Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Carmell Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how Carmell Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Carmell Therapeutics shares will generate the highest return on investment. By understating and applying Carmell Therapeutics stock market price indicators, traders can identify Carmell Therapeutics position entry and exit signals to maximize returns.
Carmell Therapeutics Return and Market Media
The median price of Carmell Therapeutics for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 is 0.36 with a coefficient of variation of 26.08. The daily time series for the period is distributed with a sample standard deviation of 0.1, arithmetic mean of 0.38, and mean deviation of 0.08. The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Acquisition by Spenlehauer Gilles of 1009 shares of Carmell Therapeutics at 0.51 subject to Rule 16b-3 | 09/06/2024 |
2 | Acquisition by Bryan Cassaday of 475 shares of Carmell Therapeutics at 0.46 subject to Rule 16b-3 | 09/10/2024 |
3 | Acquisition by Upton Richard A of 5000 shares of Carmell Therapeutics at 0.4672 subject to Rule 16b-3 | 09/13/2024 |
4 | Meteora Capital, LLC Reduces Stake in Carmell Corp | 11/15/2024 |
About Carmell Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Carmell or other stocks. Alpha measures the amount that position in Carmell Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Carmell Therapeutics Upcoming Company Events
As portrayed in its financial statements, the presentation of Carmell Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Carmell Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Carmell Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Carmell Therapeutics. Please utilize our Beneish M Score to check the likelihood of Carmell Therapeutics' management manipulating its earnings.
| 13th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Carmell Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Carmell Stock Analysis
When running Carmell Therapeutics' price analysis, check to measure Carmell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Carmell Therapeutics is operating at the current time. Most of Carmell Therapeutics' value examination focuses on studying past and present price action to predict the probability of Carmell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Carmell Therapeutics' price. Additionally, you may evaluate how the addition of Carmell Therapeutics to your portfolios can decrease your overall portfolio volatility.